Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-05T06:53:32.330Z Has data issue: false hasContentIssue false

Concerns about depression

Published online by Cambridge University Press:  16 April 2020

HM van Praag*
Affiliation:
Academic Psychiatric Centre, University of Limburg, PO Box 616, 6200 MD Maastricht, The Netherlands

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Biological depression research can boast of a number of significant achievements over the past 35 years. Yet, in spite of those achievements, the field is in danger of desiccation. Five reasons are discussed herein: 1) short-comings of the DSM-based depression classification; 2) the ever increasing number of, generally poorly validated, diagnostic categories; 3) desubjectivation of psychiatric diagnosing; 4) the lack of a dimensional (better: functional) component in diagnosing depression; and 5) horizontalism, ie the absence of attempts to group symptoms “vertically” according to their diagnostic weight. The issues are in need of urgent scientific attention, lest biological depression research will stagnate and ultimately whither. We have indicated ways to approach the issues.

Type
Editorial paper
Copyright
Copyright © Elsevier, Paris 1995

Footnotes

*

Plenary Lecture read at the 7th Congress of the Association of European Psychiatrists, Copenhagen, 18–22 September 1994.

References

Kessler, RMcGonagle, KZhao, S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry. 1994;51:8-19Google ScholarPubMed
Regier, DNarrow, WRae, DManderscheid, RLocke, BGoodwin, FThe de Facto US Mental and Addictive Disorders Service System. Epidemiologic Catchment Area Prospective 1-year Prevalence Rates of Disorders and Services. Arch Gen Psychiatry. 1993;50:85-94Google Scholar
Rickeis, KDowning, RSchweitzer, Ehassman, HAntidepressants for the treatment of generalized anxiety disorder. Arch Gen Psychiatry. 1993;50:884-95Google Scholar
Van Praag, HMA transatlantic view of the diagnosis of depressions according to the DSM-III. II. Did the DSM-III solve the problem of depression diagnosis?. Compr Psychiat. 2341982 330-7CrossRefGoogle Scholar
Van Praag, HMDiagnosing depression. Looking backward into the future. Psychiat Dev. 1989;7:375-4Google ScholarPubMed
Van Praag, HMTwo-tier diagnosing in psychiatry. Psychiatry Res. 1990;34:1-11CrossRefGoogle Scholar
Van Praag, HMReconquest of the subjective. Againts the waning of psychiatric diagnosing. Br J Psychiatry. 160 1992a 266-71Google Scholar
Van Praag, HMMake Believes in Psychiatry of the Perils of Progress. 1992b Brunner Mazel New YorkGoogle Scholar
Van Praag, HMComorbidity (psycho-) analysed. Br J Psychiatry. 1995in pressGoogle Scholar
Van Praag, HMSerotonin-related, anxiety/aggression-drivern, stressorprecipitated depression. A psychbiological hypothesis. Life Sci. 1995in pressGoogle Scholar
Van Praag, HMAsnis, GMKahn, RS , et al.. Monoamines and abnormal behavior. A multi-aminergic perspective. Br J Psychiatry. 1990;157:723-34Google Scholar
Vermes, GJesus and the world of Judaism. Philadelphia: Fortress Press, 1983Google Scholar
Submit a response

Comments

No Comments have been published for this article.